Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – online resources
    • IMPACT
      • Workshops
      • IMPACT – online resources
      • IMPACT news
      • IMPACT partners and sponsors
    • SPECC
      • Workshops
      • Online resources
      • SPECC Partners and Sponsors
      • SPECC News
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • PELT
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
        • How your donations are spent
    • Events and Challenges
    • Leaving a Legacy
    • Fundraising
      • Our fundraisers
      • Fundraising pack
      • Fundraising opportunities
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Online Shop
  • Events
  • Contact us

Pseudomyxoma peritonei

V-Theatre_lights

Pseudomyxoma peritonei is a very rare type of cancer that usually begins in the appendix as a small growth, called a polyp. More rarely it can start in other parts of the bowel, the ovary or bladder.

This polyp eventually bursts through the wall of your appendix or other organs and spreads cancerous cells to the lining of the abdominal cavity (the peritoneum). These cancerous cells produce mucus, which then collects in the abdomen as a jelly-like fluid called mucin. It is different from other forms of cancer as it spreads across the surface of abdominal organs, producing a great deal of mucus.

Hampshire Hospitals NHS Foundation Trust’s Basingstoke and North Hampshire Hospital is one of only two national specialist centres in the country treating this disease. The centre forms part of the colorectal unit, and has built upon the expertise of this unit in the management of complex rectal cancer surgery.

Patients are referred to the unit for assessment and treatment from all over the United Kingdom. Referrals can be from your GP or your consultant if you are being treated within a hospital.

For more information, please see the Hampshire Hospitals NHS Foundation Trust’s website.

Speakers from recent courses give a brief summary of their talk:

Pelican Cancer FoundationFollow

Pelican Cancer Foundation
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
22 Dec

We would like to wish you all a very Merry Christmas and a peaceful New Year - especially to all the wonderful key workers, who will be working throughout. 🎄🥂🎁

Reply on Twitter 1341352794255593477Retweet on Twitter 1341352794255593477Like on Twitter 13413527942555934771Twitter 1341352794255593477
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
7 Dec

👏

Reply on Twitter 1335864743752589312Retweet on Twitter 1335864743752589312Like on Twitter 13358647437525893122Twitter 1335864743752589312
Pelican_CancerPelican Cancer Foundation@Pelican_Cancer·
5 Dec

Let loved ones know that you are thinking of them over the festive period and send a handwritten Christmas card. Order your Christmas cards from us at http://www.pelicancancer.org/shop. 🎄(Royal Mail’s latest recommended posting dates are 18th Dec (2nd Class) and 21st Dec (1st Class). 🎄

Reply on Twitter 1335126762079068160Retweet on Twitter 1335126762079068160Like on Twitter 1335126762079068160Twitter 1335126762079068160
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in